Literature DB >> 11417237

[The value of the Wagner SL revision prosthesis for bridging large femoral defects].

H P Bircher1, U Riede, M Lüem, P E Ochsner.   

Abstract

Between 1988 and 1999 we used the Wagner SL revision prosthesis in 99 cases. The indications were aseptic and septic loosening, periprosthetic fractures, and Girdlestone situations. These were mostly Paprosky types 2 and 3 meta- and metadiaphyseal femoral bone defects. The intervention was the first revision in 49 cases and the second or up to the sixth revision in 50 cases. A transgluteal or transfemoral approach was usually chosen. We gradually reduced the anchorage area to a length of 8-12 cm. If after the first few postoperative months an osseous integration without radiolucency is achieved, a long-lasting integration can be expected. Due to considerable subsidence during the 1st year, six stems had to be replaced. Seven additional revisions were done because of hematoma and three because of seroma. According to the survival analysis, 92% of the stems remained in place after 10 years. No revision was executed between the 5th and 10th year. At the 1-year control, 96% of the patients were pain free and 90% were satisfied. Nevertheless, 80% limped and 33% used at least one crutch. Mainly because of deterioration of general health, the walking distance was considerably reduced between the 1st and the 5th postoperative year. There is little difference in the results after revision between a relatively small and an extended defect. At present, we limit the use of the SL revision stem mainly to extended defects. Careful planning of the operation is mandatory.

Entities:  

Mesh:

Year:  2001        PMID: 11417237     DOI: 10.1007/s001320050611

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  9 in total

1.  [Cementless stems of the hip. Current status].

Authors:  H Effenberger; M Imhof; U Witzel; S Rehart
Journal:  Orthopade       Date:  2005-05       Impact factor: 1.087

2.  [Principles of fixation of the cementless modular revision stem Revitan].

Authors:  B Fink; M Fuerst; M Hahn; L Thybaud; H-P Sieber; G Delling
Journal:  Unfallchirurg       Date:  2005-12       Impact factor: 1.000

3.  Distal femoral stem-bone anchorage of a cementless revision total hip arthroplasty: evaluation of 14 patients by CT.

Authors:  Rüdiger J Weiss; Fredrik Strömwall; Mats O Beckman; Karl A Hansson; André Stark
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

4.  Nonmodular Tapered Fluted Titanium Stems Osseointegrate Reliably at Short Term in Revision THAs.

Authors:  Nemandra A Sandiford; Donald S Garbuz; Bassam A Masri; Clive P Duncan
Journal:  Clin Orthop Relat Res       Date:  2016-09-26       Impact factor: 4.176

5.  Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm.

Authors:  F Harald R De Man; Parham Sendi; Werner Zimmerli; Thomas B Maurer; Peter E Ochsner; Thomas Ilchmann
Journal:  Acta Orthop       Date:  2010-12-29       Impact factor: 3.717

6.  Excellent long-term results of the Müller acetabular reinforcement ring in primary cup revision.

Authors:  Pascal Mueller Greber; Isabella Manzoni; Peter E Ochsner; Thomas Ilchmann; Lukas Zwicky; Martin Clauss
Journal:  Acta Orthop       Date:  2017-08-03       Impact factor: 3.717

7.  Long-term results of revision total hip arthroplasty with a cemented femoral component.

Authors:  Armin Pallaver; Lukas Zwicky; Lilianna Bolliger; Hans Bösebeck; Isabella Manzoni; Sabine Schädelin; Peter E Ochsner; Martin Clauss
Journal:  Arch Orthop Trauma Surg       Date:  2018-08-11       Impact factor: 3.067

8.  Stem modularity alone is not effective in reducing dislocation rate in hip revision surgery.

Authors:  Dario Regis; Andrea Sandri; Pietro Bartolozzi
Journal:  J Orthop Traumatol       Date:  2009-11-18

9.  Eradication of infection, survival, and radiological results of uncemented revision stems in infected total hip arthroplasties.

Authors:  Philipp Born; Thomas Ilchmann; Werner Zimmerli; Lukas Zwicky; Peter Graber; Peter E Ochsner; Martin Clauss
Journal:  Acta Orthop       Date:  2016-09-23       Impact factor: 3.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.